Veradigm Inc. (NASDAQ:MDRX - Get Free Report) was down 6.5% during mid-day trading on Thursday . The stock traded as low as $9.10 and last traded at $9.12. Approximately 3,170 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 1,442,525 shares. The stock had previously closed at $9.75.
Analyst Ratings Changes
Separately, StockNews.com began coverage on Veradigm in a report on Friday, December 27th. They set a "hold" rating for the company. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $11.75.
Read Our Latest Analysis on Veradigm
Veradigm Stock Performance
The firm's 50-day simple moving average is $10.04 and its two-hundred day simple moving average is $9.73.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
